Vitiligo

Latest News

JAK Inhibitors Show Favorable Risk-Benefit Profile In Vitiligo, Especially for Facial Cases
JAK Inhibitors Show Favorable Risk-Benefit Profile In Vitiligo, Especially for Facial Cases

May 2nd 2024

A new review highlighted JAK inhibitors' role in vitiligo treatment, emphasizing varying benefits, facial efficacy, and potential for sustained responses.

Fire Needle Combined With Excimer Laser Safe, Effective Therapy for Vitiligo, Review Finds
Fire Needle Combined With Excimer Laser Safe, Effective Therapy for Vitiligo, Review Finds

April 10th 2024

Countdown to RAVE!
Countdown to RAVE!

April 5th 2024

Microneedling With and Without N-acetylcysteine Prove Effective in Patients With Persistent Vitiligo
Microneedling With and Without N-acetylcysteine Prove Effective in Patients With Persistent Vitiligo

April 3rd 2024

Patients With Vitiligo Show Lower Pulmonary Embolism and Peripheral Vascular Disease Risk, but Mortality Rises with Comorbidities
Patients With Vitiligo Show Lower Pulmonary Embolism and Peripheral Vascular Disease Risk, but Mortality Rises with Comorbidities

April 2nd 2024

Video Interviews
Podcasts
The Cutaneous Connection: Deep Dive Into the World of Vitiligo

More News

© 2024 MJH Life Sciences

All rights reserved.